« Return to News | Technology Solutions

BioClinica, Mirada partner for molecular image analysis

Monday, April 2, 2012 06:35 AM

Through a newly formed partnership, BioClinica, a global provider of clinical trial management solutions, will integrate Oxford-based Mirada Medical's XD3 software solution into its imaging core lab technology to enhance its PET capabilities and expertise for molecular imaging trials.

Mirada’s integrated software will provide tools and efficient workflows for the quantification and tracking of findings for major modalities including PET, CT, MR and MR/PET. Once XD2 is integrated into BioClinica’s BioPACS and BioREAD technologies, the imaging workflow and processing programs’ will be capable of helping trial sponsors harness the superior imaging results that are achievable through PET scans and multiple modalities technology.

Through the partnership, BioClinica's PET image processing capabilities will extend oncology clinical trials with support for the following features:

  • Enhanced capabilities for PERCIST tumor response assessment criteria
  • Normalization of uptake by body weight, lean body mass or body surface area for SUV measurements
  • Registration and fusion capabilities between PET, CT and MR
  • Customizable workflow and user interface to provide flexibility in the independent read design

Furthermore, as part of this partnership, Mirada will present at BioClinica's 2012 User Conference—which is designed to help BioClinica imaging core lab customers and eClinical solution users discover new ways to run faster, more efficient clinical trials.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.